Sudden sensorineural hearing loss: Supporting the immunologic theory

Annals of Otology, Rhinology and Laryngology

Volumn 111, Issue 11, 2002, Pages 989-997

  García Berrocal, José Ramón ^a   Ramírez Camacho, Rafael ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Immunopathology; Inner ear disorders; Sudden deafness

Indexed keywords

ADENOSINE RECEPTOR STIMULATING AGENT; ANTICOAGULANT AGENT; ANTIOXIDANT; CORTICOSTEROID; FOLIC ACID; GLUTATHIONE DERIVATIVE; GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; PROTEINASE INHIBITOR;

ANTICOAGULANT THERAPY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL POPULATION; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CORTICOSTEROID THERAPY; DIAGNOSTIC TEST; DRUG DELIVERY SYSTEM; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INNER EAR; LABYRINTHITIS; LIVER TOXICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEAR MAGNETIC RESONANCE IMAGING; OSMOTIC PUMP; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0036845005     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940211101107     Document Type: Article

References (73)

1. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 1980;106:772-6.
2. Mattox DE, Lyles CA. Idiopathic sudden sensorineural hearing loss. Am J Otol 1989;10:242-7.
3. Byl FM Jr. Sudden hearing loss: Eight years' experience and suggested prognostic table. Laryngoscope 1984;94:647-61.
4. Haberkamp TJ, Tanyeri HM. Management of idiopathic sudden sensorineural hearing loss. Am J Otol 1999;20:587-95.
5. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979;88:585-9.
6. Harris JP, Woolf NK, Ryan AF, Butler DM, Richman DD. Immunologic and electrophysiological response to cytomegaloviral inner ear infection in the guinea pig. J Infect Dis 1984;150: 523-30.
7. Oldstone MBA. Virus-induced autoimmunity: Molecular mimicry as a route to autoimmune disease. J Autoimmun 1989 (suppl 2):187-94.
8. Stone JH, Francis HW. Immune-mediated inner ear disease. Curr Opin Rheumatol 2000;12:32-40.
9. García-Berrocal JR, Vicente J, Arellano B, González F, Ramírez-Camacho R. Laberintitis experimental autoinmune: Evaluación de diversos modelos en cobayas. Acta Otorrinolaringol Esp 1997;48:5-10.
10. Harris JP, Woolf NK, Ryan AF. Elaboration of systemic immunity following inner ear immunization. Am J Otolaryngol 1985;6:148-52.
11. Woolf NK, Harris JP. Cochlear pathophysiology associates with inner ear immune responses. Acta Otolaryngol (Stockh) 1986;102:353-64.
12. Tomiyama S, Harris JP. The role of the endolymphatic sac in inner ear immunity. Acta Otolaryngol (Stockh) 1987;103: 182-8.
13. Stearns GS, Keithley EM, Harris JP. Development of high endothelial venule-like characteristics in the spiral modiolar vein induced by viral labyrinthitis. Laryngoscope 1993;103:890-8.
14. Suzuki M, Harris JP. Expression of intercellular adhesion molecule-1 during inner ear inflammation. Ann Otol Rhinol Laryngol 1995;104:69-75.
15. Ichimiya I, Kurono Y, Hirano T, Mogi G. Changes in immunostaining of inner ears after antigen challenge into the scala tympani. Laryngoscope 1998;108:585-91.
16. Chen MC, Harris JP, Keithley EM. Immunohistochemical analysis of proliferating cells in a sterile labyrinthitis animal model. Laryngoscope 1998;108:651-6.
17. Takasu T, Harris JP. Reduction of inner ear inflammation by treatment with anti-ICAM-1 antibody. Ann Otol Rhinol Laryngol 1997;106:1070-5.
18. Ma C-L, Billings P, Harris JP, Keithley EM. Characterization of an experimentally induced inner ear immune response. Laryngoscope 2000;110:451-6.
19. Tomiyama S, Jinnouchi K, Ikezono T, Pawankar R, Yagi T. Experimental autoimmune labyrinthitis induced by cell-mediated immune reaction. Acta Otolaryngol (Stockh) 1999;119: 665-70.
20. Iwai H, Tomoda K, Sugiura K, Inaba M, Ikehara S, Yamashita T. T cells infiltrating from the systemic circulation proliferate in the endolymphatic sac. Ann Otol Rhinol Laryngol 1999; 108:1146-50.
21. Gloddek B, Gloddek J, Arnold W. Induction of an inner-ear-specific autoreactive T-cell line for the diagnostic evaluation of an autoimmune disease of the inner ear. Ann N Y Acad Sci 1997;830:266-76.
22. Pawankar R, Tomiyama S, Jinnouchi K, Ikezono T, Nonaka M, Yagi T. Intercellular adhesion molecule-1 expression in the inner ear of rats following secondary immune reaction in the endolymphatic sac. Acta Otolaryngol Suppl (Stockh) 1998 (suppl 539):5-14.
23. Zhang C, Huang W, Song H. Expression of vascular cell adhesion molecule-1, α4-integrin and L-selectin during inner ear immunity reaction. Acta Otolaryngol (Stockh) 2000;120: 607-14.
24. García Berrocal JR, Ramírez-Camacho R, Zurita M, Arellano B. La respuesta celular inmune precoz en la laberintitis experimental: Estudio inmunohistoquímico. Acta Otorrinolaringol Esp 2000;51:557-61.
25. García Berrocal JR, Vargas JA, Vaquero M, Ramón y Cajal S, Ramírez Camacho RA. Cogan's syndrome: An oculoaudiovestibular disease. Postgrad Med J 1999;75:262-4.
26. Wolfovitz E, Levy Y, Brook JG. Sudden deafness in a patient with temporal arteritis. J Rheumatol 1987;14:384-5.
27. Kempf HG. Ear involvement in Wegener's granulomatosis. Clin Otolaryngol 1989;14:451-6.
28. Rowe-Jones JM, Macallan DC, Sorooshian M. Polyarteritis nodosa presenting as bilateral sudden onset cochleo-vestibular failure in a young woman. J Laryngol Otol 1990;104:562-4.
29. Bowman CA, Linthicum FH Jr, Nelson RA, Mikami K, Quismorio F. Sensorineural hearing loss associated with systemic lupus erythematosus. Otolaryngol Head Neck Surg 1986; 94:197-204.
30. Cole RR, Jahrsdoerfer RA. Sudden hearing loss: An update. Am J Otol 1988;9:211-5.
31. Bernstein JM, Shanahan TC, Schaffer FM. Further observations on the role of the MHC genes and certain hearing disorders. Acta Otolaryngol (Stockh) 1996;116:666-71.
32. Yeo SW, Chang K-H, Suh B-D, Kim T-G, Han H. Distribution of HLA-A, -B and -DRB1 alleles in patients with sudden sensorineural hearing loss. Acta Otolaryngol (Stockh) 2000;120: 710-5.
33. García Berrocal JR, Ramírez-Camacho R. Immune response and immunopathology of the inner ear: An update. J Laryngol Otol 2000;114:101-7.
34. Ottaviani F, Cadoni G, Marinelli L, et al. Anti-endothelial autoantibodies in patients with sudden hearing loss. Laryngoscope 1999;109:1084-7.
35. García Berrocal JR, Ramírez Camacho R, Portero F, Vargas JA. Role of viral and Mycoplasma pneumoniae infection in idiopathic sudden sensorineural hearing loss. Acta Otolaryngol (Stockh) 2000;120:835-9.
36. Yoon TH, Paparella MM, Schachern PA. Systemic vasculitis: A temporal bone histopathologic study. Laryngoscope 1989;99:600-9.
37. Yoon TH, Paparella MM, Schachern PA, Alleva M. Histopathology of sudden hearing loss. Laryngoscope 1990;100: 707-15.
38. Schuknecht H. Ear pathology in autoimmune disease. Adv Otorhinolaryngol 1991;46:50-70.
39. Leone CA, Feghali JG, Linthicum FH Jr. Endolymphatic sac: Possible role in autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1984;93:208-9.
40. Schuknecht HF, Nadol JB Jr. Temporal bone pathology in a case of Cogan's syndrome. Laryngoscope 1994;104:1135-42.
41. Toubi E, Ben-David J, Kessel A, Podoshin L, Golan TD. Autoimmune aberration in sudden sensorineural hearing loss: Association with anti-cardiolipin antibodies. Lupus 1997;6:540-2.
42. Yoshida Y, Yamauchi S, Shinkaw A, Horiuchi M, Sakai M. Immunological and virological study of sudden deafness. Auris Nasus Larynx 1996;23:63-8.
43. García Berrocal JR, Pinilla Urraca M, Ramírez-Camacho R, González Martin F, López Cortijo C. Patología de oído interno de probable origen autoinmune y su respuesta al tratamiento esteroideo. Acta Otorrinolaringol Esp 1995;46:416-20.
44. García Berrocal JR, Ramírez Camacho R, Ochoa Sánchez LF, Millán Santos I. Enfermedad inmuno-mediada del oído interno: Una actualización. Acta Otorrinolaringol Soc Colombiana Otorrinolaringol 1999;27:157-63.
45. García Berrocal JR, Arellano B, Vargas JA, Trinidad A, Ramírez Camacho R, Vergara J. Enfermedad inmunomediada del oído interno. Presentación de casos clínicos. Acta Otorrinolaringol Esp 1997;48:565-70.
46. Nordang L, Laurent C, Mollnes TE. Complement activation in sudden deafness. Arch Otolaryngol Head Neck Surg 1998;124:633-6.
47. Pitkaranta A, Julkunen I. Sudden deafness: Lack of evidence for systemic viral infection. Otolaryngol Head Neck Surg 1998;118:397-9.
48. Hirose K, Wener MH, Duckert LG. Utility of laboratory testing in autoimmune inner ear disease. Laryngoscope 1999; 109:1749-54.
49. Sabini P, Sclafani AP. Efficacy of serologic testing in asymmetric sensorineural hearing loss. Otolaryngol Head Neck Surg 2000;122:469-76.
50. Harris JP, Sharp PA. Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss. Laryngoscope 1990;100:516-24.
51. Billings PB, Keithley EM, Harris JP. Evidence linking the 68 kilodalton antigen identified in progressive sensorineural hearing loss patient sera with heat shock protein 70. Ann Otol Rhinol Laryngol 1995;104:181-8.
52. Gower VC, Thompson AM. Localization of inducible heat shock protein mRNA in the guinea pig cochlea with a non-radioactive in situ hybridization technique. Laryngoscope 1997; 107:228-32.
53. Jarjour WN, Jeffries BD, Davis JS IV, Welch WJ, Minura T, Winfield JB. Autoantibodies to human stress proteins. A survey of various rheumatic and other inflammatory diseases. Arthritis Rheum 1991;34:1133-8.
54. García Berrocal JR, Ramírez-Camacho R, Arellano B, Vargas JA. Validity of the Western blot immunoassay for heat shock protein-70 in associated and isolated immunorelated inner ear disease. Laryngoscope 2002;112:304-9.
55. Veldman JE, Hanada T, Meeuwsen F. Diagnostic and therapeutic dilemmas in rapidly progressive sensorineural hearing loss and sudden deafness. A reappraisal of immune reactivity in inner ear disorders. Acta Otolaryngol (Stockh) 1993;113:303-6.
56. Yamanobe S, Harris JP. Inner ear-specific autoantibodies. Laryngoscope 1993;103:319-25.
57. Joliat T, Seyer J, Bernstein J, et al. Antibodies against a 30 kilodalton cochlear protein and type II and IX collagens in the serum of patients with inner ear diseases. Ann Otol Rhinol Laryngol 1992;101:1000-6.
58. Plester D, Soliman AM. Autoimmune hearing loss. Am J Otol 1989;10:188-92.
59. García Berrocal JR, Vargas JA, Ramírez-Camacho R, et al. Deficiency of naive T cells in patients with sudden deafness. Arch Otolaryngol Head Neck Surg 1997;123:712-7.
60. Morimoto C, Steinberg AD, Letvin NL, et al. A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest 1987;79:762-8.
61. Kahan A, Hamzaoui K, Ayed K. Abnormalities of T lymphocyte subsets in Behçet's disease demonstrated with anti-CD-45RA and anti-CD29 monoclonal antibodies. J Rheumatol 1992; 19:742-6.
62. Kano K, Tono T, Ushisako Y, Morimitsu T, Suzuki Y, Kodama T. Magnetic resonance imaging in patients with sudden deafness. Acta Otolaryngol Suppl (Stockh) 1994(suppl 514):32-6.
63. Fitzgerald DC, Mark AS. Sudden hearing loss: Frequency of abnormal findings on contrast-enhanced MR studies. AJNR Am J Neuroradiol 1998;19:1433-6.
64. Held P, Fellner C, Fellner F, Graf S, Seitz J, Strutz J. 3D MRI of the membranous labyrinth. An age related comparison of MR findings in patients with labyrinthine fibrosis and in persons without inner ear symptoms. J Neuroradiol 1998;25:268-74.
65. García Berrocal JR, Ramírez Camacho R, Arellano B. Isolated immune-mediated sudden sensorineural hearing loss. Profile of the typical patient [Abstract]. XXIV International Congress of Audiology, Buenos Aires, Argentina, 1998.
66. García Berrocal JR, Ramírez-Camacho R, Vargas JA, Millan I. Does the serological testing really play a role in the diagnosis of immune-mediated inner ear disease? Acta Otolaryngol (Stockh) 2002;122:243-8.
67. Wobig RJ, Kempton J, Trune DR. Steroid-responsive cochlear dysfunction in the MRL/1pr autoimmune mouse. Otolaryngol Head Neck Surg 1999;121:344-7.
68. Ruckenstein MJ, Sarwar A, Hu L, Shami H, Marion TN. Effects of immunosuppression on the development of cochlear disease in the MRL-Fas1pr mouse. Laryngoscope 1999;109:626-30.
69. Kaylie DM, Hefeneider SH, Kempton JB, et al. Decreased cochlear DNA receptor staining in MRL.MpJ-Fas1pr autoimmune mice with hearing loss. Laryngoscope 2001;111:1275-80.
70. Arellano B, García Berrocal JR, Górriz C, González FM, Vicente J, Ramírez Camacho R. Protocolo de tratamiento de la sordera súbita. Acta Otorrinolaringol Esp 1997;48:513-6.
71. Matteson EL, Tirzaman O, Facer GW, et al. Use of methotrexate for autoimmune hearing loss. Ann Otol Rhinol Laryngol 2000;109:710-4.
72. Kilpatrick JK, Sismanis A, Spencer RF, Wise CM. Low-dose oral methotrexate management of patients with bilateral Meniere's disease. Ear Nose Throat J 2000;79:82-3, 86-8, 91-2.
73. Silverstein H, Choo D, Rosenberg SI, Kuhn J, Seidman M, Stein I. Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 1996;75: 468-71, 474, 476.